To validate these findings, we conducted a western blot analysis, which demonstrated that ADAMTS1-KD and overexpression respectively suppressed and enhanced activation of EGFR and its downstream signals, including ERK and Stat3 in RCC cells. The gene discussed is EGFR; the disease is renal cell carcinoma.